Currently in Greece, intravitreal bevacizumab cannot be officially used and only the two licensed anti-VEGF agents can be provided to patients with retinal diseases in both the private and public ...
 |
| READ THE ORIGINAL POST AT www.nature.com |
How the world sees Greece
